DiaMedica Therapeutics Inc. (DMAC) Net Cash Provided by (Used in) Financing Activities USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • DiaMedica Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1 K, unchanged year-over-year.
  • DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $36.8 M.
  • DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6 K, a 100% decline from 2021.
  • DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $30.1 M, a 4.31% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $36.8 M +$36.8 M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$6 K -$30.1 M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $30.1 M +$1.24 M +4.31% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $28.8 M +$28.8 M +41107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $70 K -$21.1 M -99.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 $21.2 M +$17.7 M +499% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 $3.54 M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.